Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sequence and expression pattern of the human MAGE2 gene

C De Smet1, C Lurquin, P van der Bruggen

  • 1Ludwig Institute for Cancer Research, Brussels, Belgium.

Immunogenetics
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Wastewater Surveillance to Estimate and Characterize Hepatitis E Virus Circulation.

Food and environmental virology·2025
Same author

[Pleuroperitoneal communication: pleural effusion subsequent to the initiation of peritoneal dialysis, about a case].

Revue medicale de Bruxelles·2017
Same author

Tum variants: immunogenic variants obtained by mutagen treatment of tumor cells.

Immunology today·2014
Same author

[Prognostic factors of pregnancy in intra-uterine insemination with sperm of donor: a review of 535 cycles over 7 years].

Journal de gynecologie, obstetrique et biologie de la reproduction·2012
Same author

[Pregnancy predictive factors in case of double embryo transfer during "Top Quality" attempts].

Gynecologie, obstetrique & fertilite·2011
Same author

[Wrong side iliofascial block in a patient with hip fracture].

Annales francaises d'anesthesie et de reanimation·2010
Same journal

Genotype-phenotype correlations in autoimmune and autoinflammatory diseases: An NGS-based immunogenetic cohort study.

Immunogenetics·2026
Same journal

Elevated interleukin-36γ and gene polymorphisms implicate novel risk in essential hypertension.

Immunogenetics·2026
Same journal

Unraveling the genomic structures, conserved functional domains and evolutionary dynamics of beta-defensins in Bubalus bubalis and Ovis aries.

Immunogenetics·2026
Same journal

Genetic characterization of the TAPBP and its allelic association with BF2 in the chicken major histocompatibility complex.

Immunogenetics·2026
Same journal

Reconstructed amphibian heavy-chain constant regions support a mosaic origin of IgXA with IgY-like CH1-CH2, an intermediate CH3, and an IgM-like CH4.

Immunogenetics·2026
Same journal

Climate factors and selection shape MHC class II diversity in a montane wild sheep (Ovis ammon).

Immunogenetics·2026
See all related articles

Researchers identified the MAGE2 gene, closely related to MAGE1, which is expressed in various cancers like melanoma and lung carcinoma. MAGE2 shows broader expression in tumors than MAGE1, with both genes found only in healthy adult testes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • The human MAGE1 gene encodes an antigen recognized by T lymphocytes in melanoma.
  • Melanoma MZ2-MEL expresses MAGE1 and several related genes, including the newly identified MAGE2.

Purpose of the Study:

  • To characterize the MAGE2 gene sequence and its expression patterns.
  • To compare MAGE2 expression with MAGE1 in various tumor types and healthy tissues.

Main Methods:

  • Obtained the complete MAGE2 gene sequence.
  • Analyzed gene homology and protein sequence identity between MAGE1 and MAGE2.
  • Assessed MAGE1 and MAGE2 gene expression in melanoma, lung carcinomas, laryngeal tumors, sarcomas, and healthy adult tissues.

Main Results:

Related Experiment Videos

  • MAGE2 comprises 3 exons homologous to MAGE1, with an additional exon similar to a MAGE1 intron region.
  • The open reading frame of MAGE2 is encoded by its last exon, showing 82% sequence identity with MAGE1's last exon.
  • MAGE2 exhibits 67% protein sequence identity with MAGE1 and is expressed in a higher proportion of melanoma tumors than MAGE1.
  • MAGE2 is also expressed in small-cell lung carcinomas, other lung tumors, laryngeal tumors, and sarcomas.
  • MAGE1 and MAGE2 expression was not detected in most healthy adult tissues, except for the testis.

Conclusions:

  • MAGE2 is a distinct gene with structural and sequence homology to MAGE1.
  • MAGE2 demonstrates a broader expression profile in tumors compared to MAGE1, suggesting potential roles in different cancers.
  • The restricted expression of MAGE1 and MAGE2 in healthy adult tissues, apart from the testis, highlights their potential as cancer-specific biomarkers.